Discover
ENTX
Entera Bio Ltd.
2.96
2 x 2.13
2 x 3.90
bid
ask
-
0.07
2.31%
2 @ 07:30 PM
2.96 +0.00 (0.00%)
| Ytd | 52.58% | |
| 1y | 64.44% |
2.88
day range
3.14
1.00
52 week range
3.92
| Open | 3.14 | Prev Close | 3.03 | Low | 2.88 | High | 3.14 | Mkt Cap | 512.50M |
| Vol | 288.98K | Avg Vol | 2.69M | EPS | -0.35 | P/E | N/A | Forward P/E | -3.64 |
| Beta | 1.38 | Short Ratio | 0.54 | Inst. Own | 18.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-13 | 50-d Avg | 2.74 | 200-d Avg | 1.76 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 4.56M | ||
| Research and Development Expense | 3.20M | ||
| Selling, General and Administrative Expense | 1.36M | ||
| Operating Income | -4.56M | ||
| Net Income | -7.31M | ||
| Net Income Common Stock | -7.31M | ||
| Net Income Common Stock (USD) | -7.31M | ||
| Consolidated Income | -7.31M | ||
| Earnings per Basic Share | -0.14 | ||
| Earnings per Basic Share (USD) | -0.14 | ||
| Earnings per Diluted Share | -0.14 | ||
| Earning Before Interest & Taxes (EBIT) | -7.31M | ||
| Earning Before Interest & Taxes (USD) | -7.31M | ||
| Weighted Average Shares | 50.45M | ||
| Weighted Average Shares Diluted | 50.45M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.43M | ||
| Cash and Equivalents (USD) | 18.43M | ||
| Current Assets | 18.90M | ||
| Property, Plant & Equipment Net | 483.00K | ||
| Total Assets | 19.48M | ||
| Debt Current | 199.00K | ||
| Total Debt | 425.00K | ||
| Current Liabilities | 2.10M | ||
| Debt Non-Current | 226.00K | ||
| Total Liabilities | 12.21M | ||
| Accumulated Retained Earnings (Deficit) | -136.18M | ||
| Accumulated Other Comprehensive Income | 41.00K | ||
| Shareholders Equity | 7.27M | ||
| Shareholders Equity (USD) | 7.27M | ||
| Assets Non-Current | 584.00K | ||
| Total Debt (USD) | 425.00K | ||
| Liabilities Non-Current | 10.11M | ||
| Trade and Non-Trade Payables | 575.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 9.00K | ||
| Net Cash Flow from Financing | 9.96M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.49M | ||
| Capital Expenditure | -3.00K | ||
| Issuance (Purchase) of Equity Shares | 10.13M | ||
| Net Cash Flow from Investing | -3.00K | ||
| Net Cash Flow from Operations | -3.46M | ||
| Effect of Exchange Rate Changes on Cash | 17.00K | ||
| Share Based Compensation | 624.00K | ||